ACU-D1 is under development for the treatment of severe acne rosacea and HPV associated vulvar and perianal lesions in people with HIV. The drug candidate is a cinnamate compound. The drug candidate ...

Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...

Researchers say a compound called SYM2081 inhibits inflammation-driving mast cells in mice and human skin samples paving the ...

If you're looking for longer, fuller lashes, one eyelash serum rises above the rest: Latisse. After four months of testing, ...

For women in midlife, dry eyes can becomes even more prevalent, with approximately 61% of perimenopausal or menopausal women ...

1. A fan-fave Laneige lip mask, which honestly requires no introduction. Enriched with vitamin C, coconut oil, shea butter, ...

Researchers Develop Nanofiber Patch for Treatment of Psoriasis Nov. 12, 2024 — Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be ...

2024 has been a bumper year for beauty. Every month it felt like a new edition of Rhode Beauty’s 'Lip Peptide' launched, and ...